Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery.

Dale Morrison; Barbora Paldus; Dessi P Zaharieva; Melissa H Lee; Sara Vogrin; Alicia J Jenkins; André La Gerche; Richard J MacIsaac; Sybil A McAuley; Glenn M Ward; Peter G Colman; Carmel E M Smart; Rowen Seckold; Benyamin Grosman; Anirban Roy; Bruce R King; Michael C Riddell; David Norman O'Neal
Abstract
To compare evening and overnight hypoglycemia risk after late afternoon exercise with a nonexercise control day in adults with type 1 diabetes using automated insulin delivery (AID). Thirty adults with type 1 diabetes using AID (Minimed 670G) performed in random order 40 min high intensity interval aerobic exercise (HIE), resistance (RE), and moderate intensity aerobic exercise (MIE) exercise each separated by >1 week. The closed-loop set-point was temporarily increased 2 h pre-exercise and a snack eaten if plasma glucose was ≤126 mg/dL pre-exercise. Exercise commenced at ∼16:00. A standardized meal was eaten at ∼20:40. Hypoglycemic events were defined as a continuous glucose monitor (CGM) reading <70 mg/dL for ≥15 min. Four-hour postevening meal and overnight (00:00-06:00) CGM metrics for exercise were compared with the prior nonexercise day. There was no severe hypoglycemia. Between 00:00 and 06:00, the proportion of nights with hypoglycemia did not differ postexercise versus control for HIE (18% vs. 11%;  = 0.688), RE (4% vs. 14%;  = 0.375), and MIE (7% vs. 14%;  = 0.625). Time in range (TIR) (70-180 mg/dL), >75% for all nights, did not differ between exercise conditions and control. Hypoglycemia episodes postmeal after exercise versus control did not differ for HIE (22% vs. 7%;  = 0.219) and MIE (10% vs. 14%;  > 0.999), but were greater post-RE (39% vs. 10%;  = 0.012). Overnight TIR was excellent with AID without increased hypoglycemia postexercise between 00:00 and 06:00 compared with nonexercise days. In contrast, hypoglycemia risk was increased after the first meal post-RE, suggesting the importance of greater vigilance and specific guidelines for meal-time dosing, particularly with vigorous RE. ACTRN12618000905268.
Journal DIABETES TECHNOLOGY & THERAPEUTICS
ISSN 1557-8593
Published 01 Dec 2022
Volume 24
Issue 12
Pages 873 880 873-880
DOI 10.1089/dia.2022.0279
Type Journal Article | Research Support, Non-U.S. Gov't
Sponsorship